Details for 2017804979
Up to date per 04.04.2026
Actions
Details for 2017804979
Granted/Registered
European Patent
28.08.2019 A
25.05.2022 B1
18.10.2016
US
201662409833 P
07.06.2017
US
201762516594 P
A61K 31/53 20060101AFI20211123BHEP
Owner
Madrigal Pharmaceuticals, Inc.200 Barr Harbor Drive, Suite 400 West Conshohocken, Pennsylvania 19428US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
TAUB, Rebecca1218 Valley Road Villanova PA 19085US
Information about Fees